Cube Labs S.P.A. (IT:CUBE) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cube Labs’ subsidiary, Adamas Biotech, has secured official registration from Italy’s Ministry of Health for Theakine® Prost, a green tea-based supplement aimed at improving prostate health. The company plans to partner with firms in the urology sector for its distribution, rather than marketing it directly. This development signifies a strategic advancement in Cube Labs’ commercial endeavors within the healthcare sector.
For further insights into IT:CUBE stock, check out TipRanks’ Stock Analysis page.